KALA vs SRPT · $54.3M cap vs rev $1.13B
Kala Pharmaceuticals Inc (KALA) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
KALA currently screens at market cap $54.3M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the KALA and SRPT stock pages for the full models.
Not investment advice.